transfer of polyclonal monospecific syngeneic mouse anti-neu5gc serum also enhanced growth of transplanted syngeneic tumors bearing human-like levels of neu5gc, with tumors showing evidence for antibody deposition, enhanced angiogenesis and chronic inflammation.